MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0020264
Nine Labs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.08 Cr
▼ 34% YoY
Net profit · FY 2025
₹7.25 Lakh
Net margin 3.5%
EBITDA · FY 2025
₹1.05 Cr
EBITDA margin 50.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Nine Labs Private Limited
Data last updated:
Nine Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 February 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2008PTC057818. Its GSTIN is 36AADCN7670B1ZJ (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Munnamgi Radhika Reddy and Munnamgi Anoushka Reddy.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sy No 71 & 72 H No 2 – 159/15 Prapurna Enclave Suchitra Circle Jeedimetla, Hyderabad, Telangana, India – 500067.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.08 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹7.25 Lakh (net margin 3.5%) and EBITDA of ₹1.05 Cr (EBITDA margin 50.8%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 30% over five years.
Court records list 3 cases involving the company, including 3 filed by the company; 2 cases are pending.
Nine Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0020264). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ninelabs.co.in.
Company details
CIN U24232TG2008PTC057818
Registration Number 057818
Incorporation Date 26 February 2008
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0020264
CIN history
Nine Labs has one previous CIN (Corporate Identification Number): U24232AP2008PTC057818. The current CIN is U24232TG2008PTC057818, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2008PTC057818 | Current |
| U24232AP2008PTC057818 | Previous |
Recognitions & Rankings of Nine Labs
Contact details
Nine Labs Private Limited's registered office is in Hyderabad, Telangana. Its website is ninelabs.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSy No 71 & 72 H No 2 – 159/15 Prapurna Enclave Suchitra Circle Jeedimetla, Hyderabad, Telangana, India – 500067
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nine Labs Private Limited, buy the company report.
Comprehensive company report
Nine Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nine Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nine Labs Private Limited, buy the company report.
Financials of Nine Labs Private Limited
FY 2025 filings availableNine Labs Private Limited reported revenue of ₹2.08 Cr (down 34% YoY) for FY 2025.
Revenue · FY 2025
₹2.08 Cr ▼ 34%
Net profit · FY 2025
₹7.25 Lakh margin 3.5%
EBITDA · FY 2025
₹1.05 Cr margin 50.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 33%
5 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▲ 293%
3 years · compounded
▲ 16%
5 years · compounded
▲ 7%
Revenue has declined at a compounded annual rate (CAGR) of 30% over five years, including a 34% fall in the latest year. EBITDA rose 293% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.05 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 50.8% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nine Labs Private Limited, buy the company report.
Board of directors of Nine Labs Private Limited
Nine Labs has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munnamgi Radhika Reddy Also directs: Apithecary Pharma Private Limited | Director | 26 Feb 2008 | 18 Years 7 Months | Current |
| Munnamgi Anoushka Reddy Also directs: Apithecary Pharma Private Limited | Director | 05 Jul 2019 | 7 Years 3 Months | Current |
Peer comparison
Nine Labs Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Relic Biotechnology Private Limited | ₹2.09 Cr (FY 2025) | -8.0% | Pune, Maharashtra, India | |||
| Phenix Pharma Private Limited | ₹2.09 Cr (FY 2022) | -31.0% | Vadodara, Gujarat, India | |||
| Seven Hiills Softgel Private Limited | ₹2.08 Cr (FY 2021) | 20.0% | Hyderabad, Telangana, India | |||
| Zebx Pharmaceuticals Private Limited | ₹2.08 Cr (FY 2025) | 492.0% | Aramane Nagar, Karnataka, India | |||
| Nine Labs Private Limited this company | ₹2.08 Cr (FY 2025) | ₹7.25 Lakh | 3.5% | -34.0% | Hyderabad, Telangana, India | |
| Macromed Pharmaceuticals Private Limited | ₹2.07 Cr (FY 2020) | -1.0% | Puducherry, India | |||
| Forel Labs Private Limited | ₹2.05 Cr (FY 2024) | -87.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Nine Labs Private Limited, buy the company report.
Auditor
Nine Labs Private Limited is audited by M V NARAYANA REDDY AND CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M V NARAYANA REDDY AND CO | FY 2024 | 0023070S |
Shareholding
The shareholding of Nine Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nine Labs Private Limited, buy the company report.
Legal cases
Nine Labs Private Limited has 3 court cases on record: 3 filed by Nine Labs. 2 cases are pending and 1 is disposed.
Total cases
3
Filed by the company
3
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Court case (STC-NI) | Filed by the company against individuals | Pending |
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed by the company against Vaasavaa Pharmaceuticals PRV. Ltd., Rep.By.It S Manging Director and 4 Anothers | Disposed |
To see the full case history of Nine Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nine Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nine Labs has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCN7670B1ZJ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nine Labs Private Limited, buy the company report.
Recent activity
Nine Labs Private Limited has 6 board changes on record since 2008: 2 appointments and 4 cessations. The latest: Narender Reddy Nalla ceased to be Director on 19 Dec 2019.
AGM
Nine Labs Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Nine Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Narender Reddy Nalla ceased to be Director.
Ceased
Munnamgi Anoushka Reddy ceased to be Additional Director.
Appointed
Munnamgi Anoushka Reddy was appointed as Director.
Ceased
Narasimha Reddy Enukonda ceased to be Director.
Ceased
Kiran Kumar Nalamothu ceased to be Director.
Appointed
Munnamgi Radhika Reddy was appointed as Director.
Incorporation
26 Feb 2008
Nine Labs Private Limited was registered on 26 Feb 2008 with Roc Hyderabad & aged 18 years 7 months as per MCA records.
Frequently asked questions
Nine Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 February 2008 (18+ years old) and is registered under CIN U24232TG2008PTC057818.
Nine Labs has 2 current directors:
- Munnamgi Radhika Reddy - Director
- Munnamgi Anoushka Reddy - Director
The latest financial statements of Nine Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nine Labs is 36AADCN7670B1ZJ, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Nine Labs is U24232TG2008PTC057818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nine Labs has 3 court cases on record: 3 filed by the company. 2 are pending.
Nine Labs was incorporated on 26 February 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Nine Labs by revenue are Relic Biotechnology Private Limited, Phenix Pharma Private Limited, Seven Hiills Softgel Private Limited, Zebx Pharmaceuticals Private Limited, Macromed Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Narender Reddy Nalla ceased to be Director on 19 Dec 2019. Munnamgi Anoushka Reddy ceased to be Additional Director on 29 Jul 2019. Munnamgi Anoushka Reddy was appointed as Director on 05 Jul 2019. Nine Labs has 6 board changes on record in total.
Yes, Nine Labs is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0020264).
Nine Labs can be reached through the website ninelabs.co.in. Its registered office is in Hyderabad, Telangana, India.